PPG for Medical Conditions
Research-backed guides on how photoplethysmography monitors and detects medical conditions — from cardiac arrhythmias to metabolic disease.
PPG for Atrial Fibrillation (AFib) Detection
PPG-based AF detection identifies atrial fibrillation through the characteristic irregular and irregular rhythm produced by chaotic atrial activity. Algorithms analyze pulse-to-pulse interval irregularity extracted from wrist or finger PPG to classify AF with sensitivities of 90–97% and specificities of 94–98% in validation studies.
Read Research →PPG-Based Sleep Apnea Detection
PPG enables wearable sleep apnea screening by detecting the characteristic oxygen desaturation events (SpO2 dips below 90%), heart rate surges following apnea termination, and sympathetic nervous system activation signatures encoded in IBI and pulse amplitude. Wearable PPG achieves AHI estimation correlation r = 0.7–0.85 with polysomnography-derived AHI.
Read Research →PPG-Based Hypertension and Blood Pressure Monitoring
PPG enables cuffless blood pressure estimation through pulse transit time (PTT), waveform morphology analysis, and multi-parameter machine learning models. Current approaches achieve 5–10 mmHg accuracy after individual calibration under resting conditions, falling short of the ≤5 mmHg mean error required by ISO 81060-2 for ambulatory BP monitors.
Read Research →PPG for Diabetes Detection and Glucose Monitoring
PPG cannot directly measure blood glucose concentration, but research shows that diabetes-related vascular changes (arterial stiffness, endothelial dysfunction, autonomic neuropathy) create detectable signatures in PPG waveform morphology and HRV. Machine learning models applied to wrist PPG achieve AUC 0.75–0.85 for diabetes detection but cannot estimate real-time glucose levels.
Read Research →PPG-Based Stress Detection and Monitoring
PPG detects psychological and physiological stress through autonomic nervous system signatures: reduced HRV (particularly HF power and RMSSD), increased heart rate, decreased perfusion index (sympathetic vasoconstriction), and altered pulse waveform morphology. Machine learning models combining these features achieve 75–90% accuracy for binary stress/no-stress classification.
Read Research →PPG-Based COVID-19 Monitoring and Long COVID Assessment
PPG wearables emerged as critical COVID-19 monitoring tools for detecting silent hypoxia (SpO2 drops without dyspnea symptoms), tracking recovery HRV trajectories, and identifying autonomic dysfunction in long COVID patients. Continuous SpO2 monitoring identified early clinical deterioration up to 6 hours before clinical recognition in observational studies.
Read Research →PPG-Based Heart Failure Monitoring
PPG wearables provide non-invasive surrogates of hemodynamic status in heart failure patients through photoplethysmographic indices of cardiac output (pulse pressure proxy), pulmonary congestion indicators (peripheral perfusion, pulse wave changes), and autonomic dysfunction (severely blunted HRV). Continuous PPG monitoring can predict heart failure decompensation 3–7 days before clinical hospitalization.
Read Research →PPG-Based COPD Monitoring
PPG wearables enable COPD monitoring through continuous SpO2 tracking to detect exercise-induced and nocturnal desaturation, pulse wave changes reflecting right heart strain and pulmonary hypertension, and activity monitoring to quantify functional capacity decline preceding exacerbations.
Read Research →PPG for Peripheral Artery Disease (PAD) Assessment
PPG provides non-invasive assessment of peripheral artery disease through waveform morphology analysis at multiple limb sites. Characteristic PAD signatures include monophasic or dampened waveforms, absent dicrotic notch, prolonged systolic upstroke time, and severely reduced ankle perfusion index, all reflecting impaired distal arterial flow from stenotic lesions.
Read Research →PPG-Based Sepsis Detection and Monitoring
Sepsis produces profound microcirculatory dysfunction detectable by PPG through falling perfusion index (PI < 1%), increasing heart rate variability complexity loss, and pulse waveform changes reflecting distributive shock hemodynamics. Continuous PPG monitoring in at-risk patients can detect physiological deterioration up to 6 hours before clinical sepsis criteria are met.
Read Research →